查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球肌肉骨骼疾病市场：2024 年
市场调查报告书
商品编码
1586301

全球肌肉骨骼疾病市场：2024 年

Global Musculoskeletal System Disorder Market Research Report 2024
出版日期: | 出版商: QYResearch | 英文 188 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年全球肌肉骨骼疾病市场规模为 1,478.39 亿美元。

预计到 2030 年，市场规模将达到 1,951.82 亿美元，2024-2030 年预测期间复合年增长率为 4.19%。

2023年北美肌肉骨骼疾病市场规模为770.23亿美元。预计到 2030 年，该市场将达到 1,000.34 亿美元，2024-2030 年预测期间复合年增长率为 3.89%。

到 2023 年，亚太地区肌肉骨骼疾病市场规模将达到 260 亿美元。预计到 2030 年，该市场将达到 355.15 亿美元，2024-2030 年预测期间复合年增长率为 4.84%。

全球主要的肌肉骨骼疾病公司包括艾伯维(AbbVie)、强生(Johnson & Johnson)、史赛克(Stryker)、Zimmer Biomet、施乐辉(Smith & Nephew)、里斯托迈尔斯施贵宝( ristol-Myers Squibb)、美敦力(Medtronic)、Arthrex 和Haleon。 2023年，全球前5名供应商将占销售额约31.46%。

本报告研究了全球肌肉骨骼疾病市场，并按类型、应用、地区和参与市场的公司概况提供了市场概述、趋势。

目录

第 1 章报告概述

  • 调查范围
  • 按类型进行市场分析
  • 按应用划分的市场
  • 假设和限制
  • 研究目的
  • 目标年份

第 2 章全球成长趋势

  • 全球肌肉骨骼疾病市场前景（2019-2030）
  • 按地区划分，全球肌肉骨骼疾病呈上升趋势
  • 肌肉骨骼疾病市场动态

第3章主要进入者竞争态势

第4章肌肉□□骨骼疾病的详细数据（按类型）

  • 全球肌肉骨骼疾病市场规模（按类型）（2019-2024 年）
  • 全球肌肉骨骼疾病市场规模预测（按类型）（2025-2030 年）

第5章肌肉骨骼疾病的详细资料（依应用分类）

  • 全球肌肉骨骼疾病市场规模（按应用划分）（2019-2024 年）
  • 全球肌肉骨骼疾病市场规模预测（按应用分类）（2025-2030 年）

第 6 章北美

第 7 章欧洲

第 8 章亚太地区

第 9 章拉丁美洲

第 10 章中东和非洲

第11章主要公司简介

  • AbbVie
  • Pfizer
  • Johnson &Johnson
  • Haleon
  • Bayer
  • Biogen
  • Novartis
  • Sanofi
  • Sarepta Therapeutics
  • Merck &Co
  • Nippon Shinyaku
  • Bristol-Myers Squibb
  • Roche
  • UCB
  • Stryker
  • Zimmer Biomet
  • Smith &Nephew
  • Globus Medical
  • Medtronic
  • B Braun
  • Acumed
  • Orthofix
  • Arthrex
  • MicroPort
  • WEGO

第12章分析师的观点/结论

第13章附录

The global Musculoskeletal System Disorder market was valued at US$ 147839 million in 2023 and is anticipated to reach US$ 195182 million by 2030, witnessing a CAGR of 4.19% during the forecast period 2024-2030.

North American market for Musculoskeletal System Disorder is estimated to increase from $ 77023 million in 2023 to reach $ 100034 million by 2030, at a CAGR of 3.89% during the forecast period of 2024 through 2030.

Asia-Pacific market for Musculoskeletal System Disorder is estimated to increase from $ 26000 million in 2023 to reach $ 35515 million by 2030, at a CAGR of 4.84 % during the forecast period of 2024 through 2030.

The major global companies of Musculoskeletal System Disorder include AbbVie, Johnson & Johnson, Stryker, Zimmer Biomet, Smith & Nephew, Bristol-Myers Squibb, Medtronic, Arthrex, Haleon, etc. In 2023, the world's top five vendors accounted for approximately 31.46% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Musculoskeletal System Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Musculoskeletal System Disorder.

The Musculoskeletal System Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Musculoskeletal System Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Musculoskeletal System Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • AbbVie
  • Pfizer
  • Johnson & Johnson
  • Haleon
  • Bayer
  • Biogen
  • Novartis
  • Sanofi
  • Sarepta Therapeutics
  • Merck & Co
  • Nippon Shinyaku
  • Bristol-Myers Squibb
  • Roche
  • UCB
  • Stryker
  • Zimmer Biomet
  • Smith & Nephew
  • Globus Medical
  • Medtronic
  • B Braun
  • Acumed
  • Orthofix
  • Arthrex
  • MicroPort
  • WEGO

Segment by Type

  • Joint Disorder
  • Bone Disorder
  • Muscle Disorder
  • Other

Segment by Application

  • Hospital & Clinic
  • Retail Pharmacy
  • Other

By Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Middle East
  • Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Musculoskeletal System Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Musculoskeletal System Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 Joint Disorder
    • 1.2.3 Bone Disorder
    • 1.2.4 Muscle Disorder
  • 1.3 Market by Application
    • 1.3.1 Global Musculoskeletal System Disorder Market Growth by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Hospital & Clinic
    • 1.3.3 Retail Pharmacy
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Musculoskeletal System Disorder Market Perspective (2019-2030)
  • 2.2 Global Musculoskeletal System Disorder Growth Trends by Region
    • 2.2.1 Global Musculoskeletal System Disorder Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Musculoskeletal System Disorder Historic Market Size by Region (2019-2024)
    • 2.2.3 Musculoskeletal System Disorder Forecasted Market Size by Region (2025-2030)
  • 2.3 Musculoskeletal System Disorder Market Dynamics
    • 2.3.1 Musculoskeletal System Disorder Industry Trends
    • 2.3.2 Musculoskeletal System Disorder Market Drivers
    • 2.3.3 Musculoskeletal System Disorder Market Challenges
    • 2.3.4 Musculoskeletal System Disorder Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Musculoskeletal System Disorder Players by Revenue
    • 3.1.1 Global Top Musculoskeletal System Disorder Players by Revenue (2019-2024)
    • 3.1.2 Global Musculoskeletal System Disorder Revenue Market Share by Players (2019-2024)
  • 3.2 Global Musculoskeletal System Disorder Market by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players Ranking by Musculoskeletal System Disorder Revenue
  • 3.4 Global Musculoskeletal System Disorder Market Concentration Ratio
    • 3.4.1 Global Musculoskeletal System Disorder Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal System Disorder Revenue in 2023
  • 3.5 Global Key Players of Musculoskeletal System Disorder Head office and Area Served
  • 3.6 Global Key Players of Musculoskeletal System Disorder, Product
  • 3.7 Global Key Players of Musculoskeletal System Disorder, Founded Date
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Musculoskeletal System Disorder Breakdown Data by Type

  • 4.1 Global Musculoskeletal System Disorder Historic Market Size by Type (2019-2024)
  • 4.2 Global Musculoskeletal System Disorder Forecasted Market Size by Type (2025-2030)

5 Musculoskeletal System Disorder Breakdown Data by Application

  • 5.1 Global Musculoskeletal System Disorder Historic Market Size by Application (2019-2024)
  • 5.2 Global Musculoskeletal System Disorder Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Musculoskeletal System Disorder Market Size (2019-2030)
  • 6.2 North America Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
  • 6.3 North America Musculoskeletal System Disorder Market Size by Country (2019-2024)
  • 6.4 North America Musculoskeletal System Disorder Market Size by Country (2025-2030)
  • 6.5 United States
  • 6.6 Canada

7 Europe

  • 7.1 Europe Musculoskeletal System Disorder Market Size (2019-2030)
  • 7.2 Europe Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
  • 7.3 Europe Musculoskeletal System Disorder Market Size by Country (2019-2024)
  • 7.4 Europe Musculoskeletal System Disorder Market Size by Country (2025-2030)
  • 7.5 Germany
  • 7.6 France
  • 7.7 U.K.
  • 7.8 Italy
  • 7.9 Russia

8 Asia-Pacific

  • 8.1 Asia-Pacific Musculoskeletal System Disorder Market Size (2019-2030)
  • 8.2 Asia-Pacific Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
  • 8.3 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2019-2024)
  • 8.4 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2025-2030)
  • 8.5 China
  • 8.6 Japan
  • 8.7 South Korea
  • 8.8 Southeast Asia
  • 8.9 India
  • 8.10 Australia

9 Latin America

  • 9.1 Latin America Musculoskeletal System Disorder Market Size (2019-2030)
  • 9.2 Latin America Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
  • 9.3 Latin America Musculoskeletal System Disorder Market Size by Country (2019-2024)
  • 9.4 Latin America Musculoskeletal System Disorder Market Size by Country (2025-2030)
  • 9.5 Mexico
  • 9.6 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Musculoskeletal System Disorder Market Size (2019-2030)
  • 10.2 Middle East & Africa Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
  • 10.3 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2019-2024)
  • 10.4 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2025-2030)
  • 10.5 Middle East
  • 10.6 Africa

11 Key Players Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Company Details
    • 11.1.2 AbbVie Business Overview
    • 11.1.3 AbbVie Musculoskeletal System Disorder Introduction
    • 11.1.4 AbbVie Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.1.5 AbbVie Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Musculoskeletal System Disorder Introduction
    • 11.2.4 Pfizer Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.2.5 Pfizer Recent Development
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Company Details
    • 11.3.2 Johnson & Johnson Business Overview
    • 11.3.3 Johnson & Johnson Musculoskeletal System Disorder Introduction
    • 11.3.4 Johnson & Johnson Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.3.5 Johnson & Johnson Recent Development
  • 11.4 Haleon
    • 11.4.1 Haleon Company Details
    • 11.4.2 Haleon Business Overview
    • 11.4.3 Haleon Musculoskeletal System Disorder Introduction
    • 11.4.4 Haleon Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.4.5 Haleon Recent Development
  • 11.5 Bayer
    • 11.5.1 Bayer Company Details
    • 11.5.2 Bayer Business Overview
    • 11.5.3 Bayer Musculoskeletal System Disorder Introduction
    • 11.5.4 Bayer Revenue in Musculoskeletal System Disorder Business (2019-2024)
  • 11.6 Biogen
    • 11.6.1 Biogen Company Details
    • 11.6.2 Biogen Business Overview
    • 11.6.3 Biogen Musculoskeletal System Disorder Introduction
    • 11.6.4 Biogen Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.6.5 Biogen Recent Development
  • 11.7 Novartis
    • 11.7.1 Novartis Company Details
    • 11.7.2 Novartis Business Overview
    • 11.7.3 Novartis Musculoskeletal System Disorder Introduction
    • 11.7.4 Novartis Revenue in Musculoskeletal System Disorder Business (2019-2024)
  • 11.8 Sanofi
    • 11.8.1 Sanofi Company Details
    • 11.8.2 Sanofi Business Overview
    • 11.8.3 Sanofi Musculoskeletal System Disorder Introduction
    • 11.8.4 Sanofi Revenue in Musculoskeletal System Disorder Business (2019-2024)
  • 11.9 Sarepta Therapeutics
    • 11.9.1 Sarepta Therapeutics Company Details
    • 11.9.2 Sarepta Therapeutics Business Overview
    • 11.9.3 Sarepta Therapeutics Musculoskeletal System Disorder Introduction
    • 11.9.4 Sarepta Therapeutics Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.9.5 Sarepta Therapeutics Recent Development
  • 11.10 Merck & Co
    • 11.10.1 Merck & Co Company Details
    • 11.10.2 Merck & Co Business Overview
    • 11.10.3 Merck & Co Musculoskeletal System Disorder Introduction
    • 11.10.4 Merck & Co Revenue in Musculoskeletal System Disorder Business (2019-2024)
  • 11.11 Nippon Shinyaku
    • 11.11.1 Nippon Shinyaku Company Details
    • 11.11.2 Nippon Shinyaku Business Overview
    • 11.11.3 Nippon Shinyaku Musculoskeletal System Disorder Introduction
    • 11.11.4 Nippon Shinyaku Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.11.5 Nippon Shinyaku Recent Development
  • 11.12 Bristol-Myers Squibb
    • 11.12.1 Bristol-Myers Squibb Company Details
    • 11.12.2 Bristol-Myers Squibb Business Overview
    • 11.12.3 Bristol-Myers Squibb Musculoskeletal System Disorder Introduction
    • 11.12.4 Bristol-Myers Squibb Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.12.5 Bristol-Myers Squibb Recent Development
  • 11.13 Roche
    • 11.13.1 Roche Company Details
    • 11.13.2 Roche Business Overview
    • 11.13.3 Roche Musculoskeletal System Disorder Introduction
    • 11.13.4 Roche Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.13.5 Roche Recent Development
  • 11.14 UCB
    • 11.14.1 UCB Company Details
    • 11.14.2 UCB Business Overview
    • 11.14.3 UCB Musculoskeletal System Disorder Introduction
    • 11.14.4 UCB Revenue in Musculoskeletal System Disorder Business (2019-2024)
  • 11.15 Stryker
    • 11.15.1 Stryker Company Details
    • 11.15.2 Stryker Business Overview
    • 11.15.3 Stryker Musculoskeletal System Disorder Introduction
    • 11.15.4 Stryker Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.15.5 Stryker Recent Development
  • 11.16 Zimmer Biomet
    • 11.16.1 Zimmer Biomet Company Details
    • 11.16.2 Zimmer Biomet Business Overview
    • 11.16.3 Zimmer Biomet Musculoskeletal System Disorder Introduction
    • 11.16.4 Zimmer Biomet Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.16.5 Zimmer Biomet Recent Development
  • 11.17 Smith & Nephew
    • 11.17.1 Smith & Nephew Company Details
    • 11.17.2 Smith & Nephew Business Overview
    • 11.17.3 Smith & Nephew Musculoskeletal System Disorder Introduction
    • 11.17.4 Smith & Nephew Revenue in Musculoskeletal System Disorder Business (2019-2024)
  • 11.18 Globus Medical
    • 11.18.1 Globus Medical Company Details
    • 11.18.2 Globus Medical Business Overview
    • 11.18.3 Globus Medical Musculoskeletal System Disorder Introduction
    • 11.18.4 Globus Medical Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.18.5 Globus Medical Recent Development
  • 11.19 Medtronic
    • 11.19.1 Medtronic Company Details
    • 11.19.2 Medtronic Business Overview
    • 11.19.3 Medtronic Musculoskeletal System Disorder Introduction
    • 11.19.4 Medtronic Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.19.5 Medtronic Recent Development
  • 11.20 B Braun
    • 11.20.1 B Braun Company Details
    • 11.20.2 B Braun Business Overview
    • 11.20.3 B Braun Musculoskeletal System Disorder Introduction
    • 11.20.4 B Braun Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.20.5 B Braun Recent Development
  • 11.21 Acumed
    • 11.21.1 Acumed Company Details
    • 11.21.2 Acumed Business Overview
    • 11.21.3 Acumed Musculoskeletal System Disorder Introduction
    • 11.21.4 Acumed Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.21.5 Acumed Recent Development
  • 11.22 Orthofix
    • 11.22.1 Orthofix Company Details
    • 11.22.2 Orthofix Business Overview
    • 11.22.3 Orthofix Musculoskeletal System Disorder Introduction
    • 11.22.4 Orthofix Revenue in Musculoskeletal System Disorder Business (2019-2024)
    • 11.22.5 Orthofix Recent Development
  • 11.23 Arthrex
    • 11.23.1 Arthrex Company Details
    • 11.23.2 Arthrex Business Overview
    • 11.23.3 Arthrex Musculoskeletal System Disorder Introduction
    • 11.23.4 Arthrex Revenue in Musculoskeletal System Disorder Business (2019-2024)
  • 11.24 MicroPort
    • 11.24.1 MicroPort Company Details
    • 11.24.2 MicroPort Business Overview
    • 11.24.3 MicroPort Musculoskeletal System Disorder Introduction
    • 11.24.4 MicroPort Revenue in Musculoskeletal System Disorder Business (2019-2024)
  • 11.25 WEGO
    • 11.25.1 WEGO Company Details
    • 11.25.2 WEGO Business Overview
    • 11.25.3 WEGO Musculoskeletal System Disorder Introduction
    • 11.25.4 WEGO Revenue in Musculoskeletal System Disorder Business (2019-2024)

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

List of Tables

  • Table 1. Global Musculoskeletal System Disorder Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
  • Table 2. Global Musculoskeletal System Disorder Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
  • Table 3. Global Musculoskeletal System Disorder Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 4. Global Musculoskeletal System Disorder Market Size by Region (2019-2024) & (US$ Million)
  • Table 5. Global Musculoskeletal System Disorder Market Share by Region (2019-2024)
  • Table 6. Global Musculoskeletal System Disorder Forecasted Market Size by Region (2025-2030) & (US$ Million)
  • Table 7. Global Musculoskeletal System Disorder Market Share by Region (2025-2030)
  • Table 8. Musculoskeletal System Disorder Market Trends
  • Table 9. Musculoskeletal System Disorder Market Drivers
  • Table 10. Musculoskeletal System Disorder Market Challenges
  • Table 11. Musculoskeletal System Disorder Market Restraints
  • Table 12. Global Musculoskeletal System Disorder Revenue by Players (2019-2024) & (US$ Million)
  • Table 13. Global Musculoskeletal System Disorder Market Share by Players (2019-2024)
  • Table 14. Global Top Musculoskeletal System Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal System Disorder as of 2023)
  • Table 15. Ranking of Global Top Musculoskeletal System Disorder Companies by Revenue (US$ Million) in 2023
  • Table 16. Global 5 Largest Players Market Share by Musculoskeletal System Disorder Revenue (CR5 and HHI) & (2019-2024)
  • Table 17. Global Key Players of Musculoskeletal System Disorder, Headquarters and Area Served
  • Table 18. Global Key Players of Musculoskeletal System Disorder, Product and Application
  • Table 19. Global Key Players of Musculoskeletal System Disorder, Founded Date
  • Table 20. Mergers & Acquisitions, Expansion Plans
  • Table 21. Global Musculoskeletal System Disorder Market Size by Type (2019-2024) & (US$ Million)
  • Table 22. Global Musculoskeletal System Disorder Revenue Market Share by Type (2019-2024)
  • Table 23. Global Musculoskeletal System Disorder Forecasted Market Size by Type (2025-2030) & (US$ Million)
  • Table 24. Global Musculoskeletal System Disorder Revenue Market Share by Type (2025-2030)
  • Table 25. Global Musculoskeletal System Disorder Market Size by Application (2019-2024) & (US$ Million)
  • Table 26. Global Musculoskeletal System Disorder Revenue Market Share by Application (2019-2024)
  • Table 27. Global Musculoskeletal System Disorder Forecasted Market Size by Application (2025-2030) & (US$ Million)
  • Table 28. Global Musculoskeletal System Disorder Revenue Market Share by Application (2025-2030)
  • Table 29. North America Musculoskeletal System Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 30. North America Musculoskeletal System Disorder Market Size by Country (2019-2024) & (US$ Million)
  • Table 31. North America Musculoskeletal System Disorder Market Size by Country (2025-2030) & (US$ Million)
  • Table 32. Europe Musculoskeletal System Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 33. Europe Musculoskeletal System Disorder Market Size by Country (2019-2024) & (US$ Million)
  • Table 34. Europe Musculoskeletal System Disorder Market Size by Country (2025-2030) & (US$ Million)
  • Table 35. Asia-Pacific Musculoskeletal System Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 36. Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2019-2024) & (US$ Million)
  • Table 37. Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2025-2030) & (US$ Million)
  • Table 38. Latin America Musculoskeletal System Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 39. Latin America Musculoskeletal System Disorder Market Size by Country (2019-2024) & (US$ Million)
  • Table 40. Latin America Musculoskeletal System Disorder Market Size by Country (2025-2030) & (US$ Million)
  • Table 41. Middle East & Africa Musculoskeletal System Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 42. Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2019-2024) & (US$ Million)
  • Table 43. Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2025-2030) & (US$ Million)
  • Table 44. AbbVie Company Details
  • Table 45. AbbVie Business Overview
  • Table 46. AbbVie Musculoskeletal System Disorder Product
  • Table 47. AbbVie Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 48. AbbVie Recent Development
  • Table 49. Pfizer Company Details
  • Table 50. Pfizer Business Overview
  • Table 51. Pfizer Musculoskeletal System Disorder Product
  • Table 52. Pfizer Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 53. Pfizer Recent Development
  • Table 54. Johnson & Johnson Company Details
  • Table 55. Johnson & Johnson Business Overview
  • Table 56. Johnson & Johnson Musculoskeletal System Disorder Product
  • Table 57. Johnson & Johnson Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 58. Johnson & Johnson Recent Development
  • Table 59. Haleon Company Details
  • Table 60. Haleon Business Overview
  • Table 61. Haleon Musculoskeletal System Disorder Product
  • Table 62. Haleon Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 63. Haleon Recent Development
  • Table 64. Bayer Company Details
  • Table 65. Bayer Business Overview
  • Table 66. Bayer Musculoskeletal System Disorder Product
  • Table 67. Bayer Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 68. Biogen Company Details
  • Table 69. Biogen Business Overview
  • Table 70. Biogen Musculoskeletal System Disorder Product
  • Table 71. Biogen Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 72. Biogen Recent Development
  • Table 73. Novartis Company Details
  • Table 74. Novartis Business Overview
  • Table 75. Novartis Musculoskeletal System Disorder Product
  • Table 76. Novartis Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 77. Sanofi Company Details
  • Table 78. Sanofi Business Overview
  • Table 79. Sanofi Musculoskeletal System Disorder Product
  • Table 80. Sanofi Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 81. Sarepta Therapeutics Company Details
  • Table 82. Sarepta Therapeutics Business Overview
  • Table 83. Sarepta Therapeutics Musculoskeletal System Disorder Product
  • Table 84. Sarepta Therapeutics Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 85. Sarepta Therapeutics Recent Development
  • Table 86. Merck & Co Company Details
  • Table 87. Merck & Co Business Overview
  • Table 88. Merck & Co Musculoskeletal System Disorder Product
  • Table 89. Merck & Co Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 90. Nippon Shinyaku Company Details
  • Table 91. Nippon Shinyaku Business Overview
  • Table 92. Nippon Shinyaku Musculoskeletal System Disorder Product
  • Table 93. Nippon Shinyaku Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 94. Nippon Shinyaku Recent Development
  • Table 95. Bristol-Myers Squibb Company Details
  • Table 96. Bristol-Myers Squibb Business Overview
  • Table 97. Bristol-Myers Squibb Musculoskeletal System Disorder Product
  • Table 98. Bristol-Myers Squibb Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 99. Bristol-Myers Squibb Recent Development
  • Table 100. Roche Company Details
  • Table 101. Roche Business Overview
  • Table 102. Roche Musculoskeletal System Disorder Product
  • Table 103. Roche Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 104. Roche Recent Development
  • Table 105. UCB Company Details
  • Table 106. UCB Business Overview
  • Table 107. UCB Musculoskeletal System Disorder Product
  • Table 108. UCB Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 109. Stryker Company Details
  • Table 110. Stryker Business Overview
  • Table 111. Stryker Musculoskeletal System Disorder Product
  • Table 112. Stryker Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 113. Stryker Recent Development
  • Table 114. Zimmer Biomet Company Details
  • Table 115. Zimmer Biomet Business Overview
  • Table 116. Zimmer Biomet Musculoskeletal System Disorder Product
  • Table 117. Zimmer Biomet Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 118. Zimmer Biomet Recent Development
  • Table 119. Smith & Nephew Company Details
  • Table 120. Smith & Nephew Business Overview
  • Table 121. Smith & Nephew Musculoskeletal System Disorder Product
  • Table 122. Smith & Nephew Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 123. Globus Medical Company Details
  • Table 124. Globus Medical Business Overview
  • Table 125. Globus Medical Musculoskeletal System Disorder Product
  • Table 126. Globus Medical Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 127. Globus Medical Recent Development
  • Table 128. Medtronic Company Details
  • Table 129. Medtronic Business Overview
  • Table 130. Medtronic Musculoskeletal System Disorder Product
  • Table 131. Medtronic Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 132. Medtronic Recent Development
  • Table 133. B Braun Company Details
  • Table 134. B Braun Business Overview
  • Table 135. B Braun Musculoskeletal System Disorder Product
  • Table 136. B Braun Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 137. B Braun Recent Development
  • Table 138. Acumed Company Details
  • Table 139. Acumed Business Overview
  • Table 140. Acumed Musculoskeletal System Disorder Product
  • Table 141. Acumed Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 142. Acumed Recent Development
  • Table 143. Orthofix Company Details
  • Table 144. Orthofix Business Overview
  • Table 145. Orthofix Musculoskeletal System Disorder Product
  • Table 146. Orthofix Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 147. Orthofix Recent Development
  • Table 148. Arthrex Company Details
  • Table 149. Arthrex Business Overview
  • Table 150. Arthrex Musculoskeletal System Disorder Product
  • Table 151. Arthrex Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 152. MicroPort Company Details
  • Table 153. MicroPort Business Overview
  • Table 154. MicroPort Musculoskeletal System Disorder Product
  • Table 155. MicroPort Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 156. WEGO Company Details
  • Table 157. WEGO Business Overview
  • Table 158. WEGO Musculoskeletal System Disorder Product
  • Table 159. WEGO Revenue in Musculoskeletal System Disorder Business (2019-2024) & (US$ Million)
  • Table 160. Research Programs/Design for This Report
  • Table 161. Key Data Information from Secondary Sources
  • Table 162. Key Data Information from Primary Sources
  • Table 163. Authors List of This Report

List of Figures

  • Figure 1. Global Musculoskeletal System Disorder Market Size Comparison by Type (2019-2030) & (US$ Million)
  • Figure 2. Global Musculoskeletal System Disorder Market Share by Type: 2023
  • Figure 3. Global Musculoskeletal System Disorder Market Share by Type: 2030
  • Figure 4. Global Musculoskeletal System Disorder Market Size by Application (2019-2030) & (US$ Million)
  • Figure 5. Global Musculoskeletal System Disorder Market Share by Application: 2023
  • Figure 6. Global Musculoskeletal System Disorder Market Share by Application: 2030
  • Figure 7. Hospital & Clinic Case Studies
  • Figure 8. Retail Pharmacy Case Studies
  • Figure 9. Musculoskeletal System Disorder Report Years Considered
  • Figure 10. Global Musculoskeletal System Disorder Market Size (US$ Million), Year-over-Year: 2019-2030
  • Figure 11. Global Musculoskeletal System Disorder Market Size, (US$ Million), 2019 VS 2024 VS 2030
  • Figure 12. Global Musculoskeletal System Disorder Market Share by Region: 2023
  • Figure 13. Global Musculoskeletal System Disorder Market Share by Region: 2030
  • Figure 14. Global Musculoskeletal System Disorder Market Share by Players in 2023
  • Figure 15. The Top 5 Players Market Share by Musculoskeletal System Disorder Revenue in 2023
  • Figure 16. The Top 10 Players Market Share by Musculoskeletal System Disorder Revenue in 2023
  • Figure 17. North America Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 18. North America Musculoskeletal System Disorder Market Share by Country (2019-2030)
  • Figure 19. United States Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 20. Canada Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 21. Europe Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 22. Europe Musculoskeletal System Disorder Market Share by Country (2019-2030)
  • Figure 23. Germany Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 24. France Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 25. U.K. Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 26. Italy Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 27. Russia Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 28. Asia-Pacific Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 29. Asia-Pacific Musculoskeletal System Disorder Market Share by Region (2019-2030)
  • Figure 30. China Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 31. Japan Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 32. South Korea Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 33. Southeast Asia Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 34. India Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 35. Australia Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 36. Latin America Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 37. Latin America Musculoskeletal System Disorder Market Share by Country (2019-2030)
  • Figure 38. Mexico Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 39. Brazil Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 40. Middle East & Africa Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 41. Middle East & Africa Musculoskeletal System Disorder Market Share by Country (2019-2030)
  • Figure 42. Middle East Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 43. Africa Musculoskeletal System Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 44. AbbVie Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 45. Pfizer Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 46. Johnson & Johnson Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 47. Haleon Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 48. Bayer Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 49. Biogen Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 50. Novartis Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 51. Sanofi Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 52. Sarepta Therapeutics Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 53. Merck & Co Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 54. Nippon Shinyaku Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 56. Roche Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 57. UCB Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 58. Stryker Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 59. Zimmer Biomet Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 60. Smith & Nephew Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 61. Globus Medical Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 62. Medtronic Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 63. B Braun Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 64. Acumed Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 65. Orthofix Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 66. Arthrex Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 67. MicroPort Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 68. WEGO Revenue Growth Rate in Musculoskeletal System Disorder Business (2019-2024)
  • Figure 69. Bottom-up and Top-down Approaches for This Report
  • Figure 70. Data Triangulation
  • Figure 71. Key Executives Interviewed